bioRxivNeurosciencePreprint
Targeting Histamine H3 Receptors to Suppress NGF-Driven Hyperexcitability in Neuropathic Pain
Ajeet KumariD, Rakesh Kumar, Poonam KumariiD, Aditi BagadeiD, Anjali YadaviD, Boda Arun Kumar, Shalini DograiD, Deepmala Umrao, Bryan A. CopitsiD, Charles F. ZorumskiiD, Steven J. MennerickiD, Prem Narayan YadaviD
Abstract
Peripheral nerve injury induces long-lasting changes in sensory neurons that contribute to the development of neuropathic pain. Although the histamine H3 receptor (H3R) is best known for regulating neurotransmitter release in the central nervous system, its expression and role in dorsal root ganglia (DRG) remain poorly understood. In this study, we examined the expression, cellular distribution, and functional role of H3 R in DRG and implications in neuropathic pain. Sciatic nerve injury increased membrane-associated H3R protein expression in the DRG, suggesting enhanced receptor trafficking or stabilization at the neuronal membrane. Single-cell transcriptomic analysis revealed that H3R mRNA expression in DRG is predominantly restricted in peptidergic sensory neurons and C-LTMRs neurons. Fluorescence imaging and transcriptomic analysis also suggest that the majority of H3R co-express with TrkA (a NGF receptor) sensory neuron populations. These findings identify a subset of NGF-responsive nociceptors in which H3R may directly influence injury-induced sensitization. Pain behavior assessment demonstrated a paradoxical role of an H3R inverse agonist (GSK334429), which reduces mechanical hypersensitivity caused by chronic constriction injury (CCI) with no change in thermal pain. Patch-clamp recordings show that the GSK334429 attenuates NGF-induced hyperexcitability in DRG neuronal cultures. Overall, our work suggests a contributing role of H3R in modality-specific effects on sensory processing through its enrichment in specific neuronal populations in DRG.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting Gi/o-coupled GPCRs to inhibit nociceptors: insights from the serotonin receptor Htr1b and triptans
Jing Peng, Brianna T Sanchez, … David D. Ginty·Cell Reports MedicinePeer-reviewed·Jul 30, 2026
- A role for protease activated receptor type 3 (PAR3) in nociception demonstrated through development of a novel peptide agonist
Juliet M. Mwirigi, Moeno Kume, … Theodore John Price·Journal of PainPeer-reviewed·Jan 12, 2021
- GPR30 in spinal cholecystokinin-positive neurons modulates neuropathic pain
Qing Chen, Hui Bing K. Wu, … Xinzhong Chen·eLifePeer-reviewed·Dec 23, 2025
- Neuronal C-Reactive Protein Mediates Neuropathic Pain by Activating Nociceptive FcγRI-Coupled Signaling
- Schwann cell p75NTR sustains persistent pain downstream to NGF through ROS-dependent TRPA1 signaling
Matilde Marini, Alice Papini, … Romina Nassini·bioRxiv·Aug 20, 2026
- Kir2.1 modulation in macrophages sensitises dorsal root ganglion neurons through TNF secretion after nerve injury
Elena A. Konnova, Alexandru‐Florian Deftu, … Marc Rene Suter·bioRxiv·Jun 21, 2023